Research Article
BibTex RIS Cite

DİŞ HEKİMLİĞİ GÜNLÜK PRATİĞİNDE KARACİĞER YETMEZLİĞİ OLGULARINDA ANTİBİYOTİK TEDAVİSİNİN YÖNETİMİ

Year 2021, , 2 - 11, 15.06.2021

Sema Ketenci N. Gökçe Acet

https://doi.org/10.54270/atljm.2021.1

Abstract

Dental ekip, hastaya zarar vermeden diş sağlığını yönetmek zorundadır. Diş hastalıkları bulaşıcı olmayan, önlenebilir kronik hastalıklardır ancak hastanın tespit edilmemiş sistemik hastalığının olması durumunda olumsuz durumlara yol açılabilir. Vaka odaklı çalışmaya paralel, çeşitli rahatsızlıklar yaşayan hastaların diş problemlerinin çözüm odaklı tedavisi esnasında; genel tıp bilgisine uygun klinik tanı koyulmalı ve hastanın tıbbi özgeçmişi incelenerek gerekli ilacın reçete edilmesi için dikkatli davranılmalıdır. Teşhis, tedavi ve bakım süreçlerinde aynı karede buluşan hekim ve hasta arasında, sağlık ve hukuki sorun oluşturabilecek yaklaşımlardan kaçınılmalıdır.
Sistemik hastalıklardan karaciğer enflamasyonunun başlamasından transplantasyona kadar uzanan süreç içerisinde oluşabilecek diş tedavi yönetimini belirginleştirecek az sayıda kılavuz bulunmaktadır ve klinik araştırma sonuçları yetersizdir. Bu derlemede, karaciğer rahatsızlığı olan hastaların diş bakım uygulamalarında tavsiye niteliğinde öneriler ve ileride hazırlanacak kılavuzlara temel oluşturabilecek bilgiler
gerekçeleriyle beraber yer almaktadır.

Keywords

Karaciğer rahatsızlıkları antibiyotikler Peridental enfeksiyonlar

References

  • Düzenli, T., & Demirci, H. Akut Karaciğer Yetmezliği..http://guncel.tgv.org.tr/journal/71/pdf/100540.pdf . Son erişim : Mart 2021
  • Mowat AP: Liver transplantation. In Liver Disorders in Childhood, 3rd Ed. Oxford: Butterworth-Heinemann Ltd. 1994, pp 433-52
  • EASL Clinical Practical Guidelines on the management of acute (fulminant) liverfailure. JHepatol. 2017 May;66(5):1047-1081.
  • BroomeU,BergquistA.:Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis. 2006;26(1):31-41.
  • Matsumoto T, Kobayashi S, Shimizu H, Nakajima M, Watanabe S, Kita- mi N, Sato N, Abe H, Aoki Y, Hoshi T, Hashimoto H. The liver in collagen diseases: pathologic study of160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia ofthe liver. Liver 2000: 20: 366–373
  • Dolar E.Karaciğer sirozu. Klinik karaciğer hastalıkları. Bursa, Nobel-Güneş tıp kitapevi, 2002,pp.343–361
  • Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009;361: p. 1279-90
  • Ryckman FC, Bucuvalas JC, Nathan J, Alonso M, Tiao G, Balistreri WF: Outcomes following liver transplantation. Seminars in Pediatric Surgery. 2008;17:123-130
  • VaroE,PadinE,OteroE,etal:Cardiovascularrisk factors in liver allograft recipients: relationship with immunosuppressive therapy. Transplantation Proceedings. 2002;34(5):1553-1554.
  • Karaciğer Hastalıkları Patolojisi Ek Ders Notları. Yrd.Doç.Dr. Gülbin Şennazlı http://cdn.istanbul.edu.tr/FileHandler2.ashx?f=karaciger-hastaliklarinin-patolojisi.pdf Son erişim : Mart 2021
  • Shihab FS. Metabolic complications. In: Norman DJ, Turka LA, editors. Primer on transplantation. 2nd ed. Mt Laurel, NJ: American Society of Transplantation; 2001. p. 247-56.
  • Little JW, Falace DA, Miller CS, Rhodus NL. Dental management of the medically compromised patient. 6th ed. St Louis: Mosby, Inc; 2002. p. 501-25.
  • Douglas LR, Douglass JB, Sieck JO, Smith PJ. Oral management of the patient with end-stage liver disease and the liver transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:55-64.
  • Tyler MT, Lozada-Nur, F, Glick, M, editors. Clinician’s guide to treatment of medically complex dental patients. 2nd ed. Baltimore: The American Academy of Oral Medicine; 2001.
  • James Guggenheimer, DDS, a Bijan Eghtesad, MD, b and Debra J. Stock, Dental management of the (solid) organ transplant patientMS, BSN, RN, CCTC, c Pittsburgh, Pa UNIVERSITY OF PITTSBURGH
  • Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;277:1794-801.
  • Asikainen, S., and S. Alaluusua. “Bacteriology of dental infections.” European heart journal 14 (1993): 43-50.
  • Reynolds-Campbell, Glendee, Alison Nicholson, and Camille-Ann Thoms-Rodriguez. “Oral bacterial infections: diagnosis and management.” Dental Clinics 61.2 (2017): 305-318.
  • Robertson,D., andA.J.Smith.“The microbiology of the acute dental abscess.” Journal of medical microbiology 58.2 (2009): 155-162
  • Whitington PF, Balistreri WF: Liver transplantation in pediatrics: indications, contraindications, and pretransplant management. J Pediatr 118:169-77, 1991.
  • Majewski RF, Hess J, Kabani S, Ramanathan G: Dental find ings in a patient with biliary atresia. J Clin Pediatr Dent 18:32-37, 1993.
  • Hosey MT, Gordon G, Kelly DA, Shaw L: Oral findings in children with livertransplants. Int J Paediatr Dent 5:29-34, 1995.
  • Morisaki I, Abe K, Tong LSM, Kato K, Sobue S: Dental find ings of children with biliary atresia: report of seven cases. ASDC J Dent Child 57:220-23, 1990.
  • Belanger GK, Sanger R, Casamassimo PS, Bystrom EB: Oral and systemic findings in biliary atresia: report of 11 cases. Pediatr Dent 4:322-26, 1982.
  • Seow WK, Shepherd RW, Ong TH: Oral changes associated with end-stage liver disease and liver transplantation: implications for dental management. ASDC J Dent Child 58:474- 80, 1991.
  • Zaia AA, Graner E, deAlmeida OP, Scully C: Oral changes associated with biliary atresia and liver transplantation. J Clin Pediatr Dent 18:38-42, 1993.
  • Kalayoglu M, Stratta RJ, Sollinger HW, Hoffman RM, D’Alessandro AM, Pirsch JD, Belzer FO: Liver transplantation in infants and children. J Pediatr Surg 24:70-76, 1989.
  • https://www.researchgate.net/publication/5267241 Son erişim : Mart 2021
  • https://onlinelibrary.wiley.com/doi/full/10.1111/idj.12146 Son erişim : Mart 2021
  • McEvoy GK, editor. AHFS drug information 2005. Bethesda (MD): American Society of Health-System Pharmacists, American Hospital Formulary Service; 2005.
  • Mosby ’s drug consult. 15th edition. St. Louis (MO): Mosby; 2005.
  • Lewis GP, Jusko WJ. Pharmacokinetics of ampicillin in cirrhosis. Clin Pharmacol Ther 1975; 18: 475–84.
  • Sambatakou, Helen, et al. “Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: the significance of penetration in the ascitic fluid.” International journal of antimicrobial agents 18.5 (2001): 441-444.
  • Vuppalanchi, Raj, et al. “Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt.” Journal of clinical gastroenterology 45.7 (2011): 638-642.
  • Amarapurkar, Deepak N. “Prescribing medications in patients with decompensated liver cirrhosis.” International journal of hepatology 2011 (2011).
  • Lewis, J. H., and J. G. Stine. “prescribing medications in patients with cirrhosis–a practical guide.” Alimentary pharmacology & therapeutics 37.12 (2013): 1132-1156.
  • Segarra-Newnham, Marisel, and Amy Henneman. “Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in patients without gastrointestinal bleeding.” Annals of Pharmacotherapy 44.12 (2010): 1946-1954.
  • Peterson MC. Spontaneous bacterial peritonitis from Streptococcus salivarius in a compromised host. J Infect 2002;45(3):197–8.
  • Olyaei AJ, de Mattos AM, Bennett WM. Commonly used drugs and interactions. In: Norman DJ, Turka LA, editors. Primer on transplantation. 2nd ed. Mt Laurel (NJ): American Society of Transplantation; 2001. p. 99-113.
  • Golla K, Epstein JB, Cabay RJ. Liver disease: current perspectives on medical and dental management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:516–21.
  • Madden AM, Bradbury W, Morgan MY. Taste perception in cirrhosis:its relationship to circulating micronutrients and food preferences. Hepatology 1997;6:40–8.
  • Mandel L, Hamele-Bena D. Alcoholic parotid sialadenosis. J Am Dent Assoc 1997;128: 1411–5.
  • https://www.researchgate.net/profile/F_Firriolo/publication/6794913_Dental_Management_of_Patients_with_End-Stage_Liver_Disease/links/5b1ff0c1a6fdcc69745ceaa4/Dental-Management-of-Patients-with-End-Stage-Liver-Disease.pdf Son erişim : Mart 2021
  • Glick M. Medical considerations for dental care of patients with alcohol-related liver disease. J Am Dent Assoc 1997;128(8):61–70.
  • Howden CW, Birnie GG, Brodie MJ. Drug metabolism in liver disease. Pharmacol Ther 1989;40:439–74.

Year 2021, , 2 - 11, 15.06.2021

Sema Ketenci N. Gökçe Acet

https://doi.org/10.54270/atljm.2021.1

Abstract

References

  • Düzenli, T., & Demirci, H. Akut Karaciğer Yetmezliği..http://guncel.tgv.org.tr/journal/71/pdf/100540.pdf . Son erişim : Mart 2021
  • Mowat AP: Liver transplantation. In Liver Disorders in Childhood, 3rd Ed. Oxford: Butterworth-Heinemann Ltd. 1994, pp 433-52
  • EASL Clinical Practical Guidelines on the management of acute (fulminant) liverfailure. JHepatol. 2017 May;66(5):1047-1081.
  • BroomeU,BergquistA.:Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis. 2006;26(1):31-41.
  • Matsumoto T, Kobayashi S, Shimizu H, Nakajima M, Watanabe S, Kita- mi N, Sato N, Abe H, Aoki Y, Hoshi T, Hashimoto H. The liver in collagen diseases: pathologic study of160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia ofthe liver. Liver 2000: 20: 366–373
  • Dolar E.Karaciğer sirozu. Klinik karaciğer hastalıkları. Bursa, Nobel-Güneş tıp kitapevi, 2002,pp.343–361
  • Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009;361: p. 1279-90
  • Ryckman FC, Bucuvalas JC, Nathan J, Alonso M, Tiao G, Balistreri WF: Outcomes following liver transplantation. Seminars in Pediatric Surgery. 2008;17:123-130
  • VaroE,PadinE,OteroE,etal:Cardiovascularrisk factors in liver allograft recipients: relationship with immunosuppressive therapy. Transplantation Proceedings. 2002;34(5):1553-1554.
  • Karaciğer Hastalıkları Patolojisi Ek Ders Notları. Yrd.Doç.Dr. Gülbin Şennazlı http://cdn.istanbul.edu.tr/FileHandler2.ashx?f=karaciger-hastaliklarinin-patolojisi.pdf Son erişim : Mart 2021
  • Shihab FS. Metabolic complications. In: Norman DJ, Turka LA, editors. Primer on transplantation. 2nd ed. Mt Laurel, NJ: American Society of Transplantation; 2001. p. 247-56.
  • Little JW, Falace DA, Miller CS, Rhodus NL. Dental management of the medically compromised patient. 6th ed. St Louis: Mosby, Inc; 2002. p. 501-25.
  • Douglas LR, Douglass JB, Sieck JO, Smith PJ. Oral management of the patient with end-stage liver disease and the liver transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:55-64.
  • Tyler MT, Lozada-Nur, F, Glick, M, editors. Clinician’s guide to treatment of medically complex dental patients. 2nd ed. Baltimore: The American Academy of Oral Medicine; 2001.
  • James Guggenheimer, DDS, a Bijan Eghtesad, MD, b and Debra J. Stock, Dental management of the (solid) organ transplant patientMS, BSN, RN, CCTC, c Pittsburgh, Pa UNIVERSITY OF PITTSBURGH
  • Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;277:1794-801.
  • Asikainen, S., and S. Alaluusua. “Bacteriology of dental infections.” European heart journal 14 (1993): 43-50.
  • Reynolds-Campbell, Glendee, Alison Nicholson, and Camille-Ann Thoms-Rodriguez. “Oral bacterial infections: diagnosis and management.” Dental Clinics 61.2 (2017): 305-318.
  • Robertson,D., andA.J.Smith.“The microbiology of the acute dental abscess.” Journal of medical microbiology 58.2 (2009): 155-162
  • Whitington PF, Balistreri WF: Liver transplantation in pediatrics: indications, contraindications, and pretransplant management. J Pediatr 118:169-77, 1991.
  • Majewski RF, Hess J, Kabani S, Ramanathan G: Dental find ings in a patient with biliary atresia. J Clin Pediatr Dent 18:32-37, 1993.
  • Hosey MT, Gordon G, Kelly DA, Shaw L: Oral findings in children with livertransplants. Int J Paediatr Dent 5:29-34, 1995.
  • Morisaki I, Abe K, Tong LSM, Kato K, Sobue S: Dental find ings of children with biliary atresia: report of seven cases. ASDC J Dent Child 57:220-23, 1990.
  • Belanger GK, Sanger R, Casamassimo PS, Bystrom EB: Oral and systemic findings in biliary atresia: report of 11 cases. Pediatr Dent 4:322-26, 1982.
  • Seow WK, Shepherd RW, Ong TH: Oral changes associated with end-stage liver disease and liver transplantation: implications for dental management. ASDC J Dent Child 58:474- 80, 1991.
  • Zaia AA, Graner E, deAlmeida OP, Scully C: Oral changes associated with biliary atresia and liver transplantation. J Clin Pediatr Dent 18:38-42, 1993.
  • Kalayoglu M, Stratta RJ, Sollinger HW, Hoffman RM, D’Alessandro AM, Pirsch JD, Belzer FO: Liver transplantation in infants and children. J Pediatr Surg 24:70-76, 1989.
  • https://www.researchgate.net/publication/5267241 Son erişim : Mart 2021
  • https://onlinelibrary.wiley.com/doi/full/10.1111/idj.12146 Son erişim : Mart 2021
  • McEvoy GK, editor. AHFS drug information 2005. Bethesda (MD): American Society of Health-System Pharmacists, American Hospital Formulary Service; 2005.
  • Mosby ’s drug consult. 15th edition. St. Louis (MO): Mosby; 2005.
  • Lewis GP, Jusko WJ. Pharmacokinetics of ampicillin in cirrhosis. Clin Pharmacol Ther 1975; 18: 475–84.
  • Sambatakou, Helen, et al. “Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: the significance of penetration in the ascitic fluid.” International journal of antimicrobial agents 18.5 (2001): 441-444.
  • Vuppalanchi, Raj, et al. “Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt.” Journal of clinical gastroenterology 45.7 (2011): 638-642.
  • Amarapurkar, Deepak N. “Prescribing medications in patients with decompensated liver cirrhosis.” International journal of hepatology 2011 (2011).
  • Lewis, J. H., and J. G. Stine. “prescribing medications in patients with cirrhosis–a practical guide.” Alimentary pharmacology & therapeutics 37.12 (2013): 1132-1156.
  • Segarra-Newnham, Marisel, and Amy Henneman. “Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in patients without gastrointestinal bleeding.” Annals of Pharmacotherapy 44.12 (2010): 1946-1954.
  • Peterson MC. Spontaneous bacterial peritonitis from Streptococcus salivarius in a compromised host. J Infect 2002;45(3):197–8.
  • Olyaei AJ, de Mattos AM, Bennett WM. Commonly used drugs and interactions. In: Norman DJ, Turka LA, editors. Primer on transplantation. 2nd ed. Mt Laurel (NJ): American Society of Transplantation; 2001. p. 99-113.
  • Golla K, Epstein JB, Cabay RJ. Liver disease: current perspectives on medical and dental management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:516–21.
  • Madden AM, Bradbury W, Morgan MY. Taste perception in cirrhosis:its relationship to circulating micronutrients and food preferences. Hepatology 1997;6:40–8.
  • Mandel L, Hamele-Bena D. Alcoholic parotid sialadenosis. J Am Dent Assoc 1997;128: 1411–5.
  • https://www.researchgate.net/profile/F_Firriolo/publication/6794913_Dental_Management_of_Patients_with_End-Stage_Liver_Disease/links/5b1ff0c1a6fdcc69745ceaa4/Dental-Management-of-Patients-with-End-Stage-Liver-Disease.pdf Son erişim : Mart 2021
  • Glick M. Medical considerations for dental care of patients with alcohol-related liver disease. J Am Dent Assoc 1997;128(8):61–70.
  • Howden CW, Birnie GG, Brodie MJ. Drug metabolism in liver disease. Pharmacol Ther 1989;40:439–74.
There are 45 citations in total.

Details

Primary Language Turkish
Subjects Pharmacology and Pharmaceutical Sciences (Other)
Journal Section Research Articles
Authors

Sema Ketenci This is me 0000-0002-6695-7003

N. Gökçe Acet This is me

Publication Date June 15, 2021
Published in Issue Year 2021

Cite

Vancouver Ketenci S, Acet NG. DİŞ HEKİMLİĞİ GÜNLÜK PRATİĞİNDE KARACİĞER YETMEZLİĞİ OLGULARINDA ANTİBİYOTİK TEDAVİSİNİN YÖNETİMİ. ATLJM. 2021;1(1):2-11.